MedTrace Logo

Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study

NCT04881578 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-05-13

No results posted yet for this study

Summary

The aim of the ALFA ROMEO study is to better understand the association between cryptogenic stroke, PFO, PFO closure and AF.

Conditions

Interventions

OTHER

continuous cardiac monitoring before and after transcatheter PFO closure

Data will be assessed from patients with cryptogenic stroke and planned PFO occlusion who undergo the contemporary ICM protocols to search for silent AF

Sponsors & Collaborators

  • Raban Jeger

    lead OTHER

Principal Investigators

  • Raban Jeger, Prof Dr med · University Hospital, Basel, Switzerland

  • Tobias Reichlin, Prof Dr med · University Hospital Bern Inselspital, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04881578 on ClinicalTrials.gov